Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

A role for SHPS-1/SIRPα1 in IL-1β- and TNFα-dependent signaling

Abstract

We investigated the role of SHPS-1/SIRPα1 in IL-1β- and TNFα-dependent signaling that leads to the activation of Erk 1/2 and Akt. Treatment of Balb3T3 cells with IL-1β or TNFα activated tyrosine phosphorylation of SHPS-1, its association with SHP-2 and the phosphorylation of Erk 1/2 and Akt. PP1, a specific inhibitor for the Src family protein tyrosine kinases, strongly inhibited tyrosine phosphorylation of SHPS-1 and complex formation of SHPS-1 with SHP-2 by IL-1β. In addition, PP1 substantially inhibited the IL-2β- and TNFα-dependent activation of Erk 1/2 and Akt. Exogenous expression of either SHPS-1 mutants that lack SHP-2 binding function or a dominant negative mutant of SHP-2 markedly inhibited the activation of Erk 1/2 and Akt by IL-1β, whereas wild type SHPS-1 did not. Moreover, IL-1β-stimulation induced association of SHPS-1 with IL-1RAcP, a second subunit of IL-1 receptor, whereas expression of SHPS-1 mutant that lack SHP-2 binding function clearly blocked the association and tyrosine phosphorylation of endogenous SHPS-1. Taken together, our results strongly suggest that activation of Erk 1/2 and Akt by proinflammatory cytokines requires tyrosine phosphorylation of SHPS-1 and subsequent association of SHPS-1 with SHP-2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Adachi M, Sekiya M, Miyachi T, Matsuno K, Hinoda Y, Imai K, Yachi A . 1992 FEBS Lett. 314: 335–339

  • Araki T, Yamada M, Ohnishi H, Sano SI, Hatanaka H . 2000 J. Neurochem. 75: 1502–1510

  • Bankers-Fulbright JL, Kalli KR, McKean DJ . 1996 Life Sci. 59: 61–83

  • Cullinan EB, Kwee L, Nunes P, Shuster DJ, Ju G, McIntyre KW, Chizzonite RA, Labow MA . 1998 J. Immunol. 161: 5614–5620

  • Dinarello CA, Wolff SM . 1993 N. Engl. J. Med. 328: 106–113

  • Dinarello CA . 1994 FASEB J. 8: 1314–1325

  • Dinarello CA . 1996 Blood 87: 2095–2147

  • Freeman RM, Plutzky Jr J, Neel BG . 1992 Proc. Natl. Acad. Sci. USA 89: 11239–11243

  • Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G . 1995 J. Biol. Chem. 270: 13757–13765

  • Hamaguchi M, Matsuyoshi N, Ohnishi Y, Gotoh B, Takeichi M, Nagai Y . 1993 EMBO J. 12: 307–314

  • Kampschmidt RF . 1984 J. Leuk. Biol. 36: 341–355

  • Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J, Ullrich A . 1997 Nature 386: 181–186

  • Kurata H, Thant AA, Matsuo S, Senga T, Okazaki K, Hotta N, Hamaguchi M . 2000 Exp. Cell Res. 254: 180–188

  • Lu W, Gong D, Bar-Sagi D, Cole PA . 2001 Mol. Cell. 8: 759–769

  • Machida K, Matsuda S, Yamaki K, Senga T, Thant AA, Kurata H, Miyazaki K, Hayashi K, Okuda T, Kitamura T, Hayakawa T, Hamaguchi M . 2000 Oncogene 19: 1710–1718

  • Madge LA, Pober JS . 2000 J. Biol. Chem. 275: 15458–15465

  • Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB . 1999 Nature 401: 82–85

  • Senga T, Miyazaki K, Machida K, Iwata H, Matsuda S, Nakashima I, Hamaguchi M . 2000 Oncogene 19: 273–279

  • Sizemore N, Leung S, Stark GR . 1999 Mol. Cell. Biol. 19: 4798–4805

  • Takada T, Matozaki T, Takeda H, Fukunaga K, Noguchi T, Fujioka Y, Okazaki I, Tsuda M, Yamao T, Ochi F, Kasuga M . 1998 J. Biol. Chem. 273: 9234–9242

  • Takeda H, Matozaki T, Fujioka Y, Takada T, Noguchi T, Yamao T, Tsuda M, Ochi F, Fukunaga K, Narumiya S, Yamamoto T, Kasuga M . 1998 Oncogene 16: 3019–3027

  • Tartaglia LA, Goeddel DV . 1992 Immunol. Today 13: 151–153

  • Thant AA, Sein TT, Liu E, Machida K, Kikkawa F, Koike T, Seiki M, Matsuda S, Hamaguchi M . 1999 Oncogene 18: 6555–6563

  • Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, Hanafusa H, Choi Y . 1999 Mol. Cell 4: 1041–1049

  • Wu CJ, Chen Z, Ullrich A, Greene MI, O'Rourke DM . 2000 Oncogene 19: 3999–4010

  • Yang CM, Luo SF, Wang CC, Chiu CT, Chien CS, Lin CC, Hsiao LD . 2000 Br. J. Pharmacol. 130: 891–899

  • You M, Flick LM, Yu D, Feng GS . 2001 J. Exp. Med. 193: 101–110

Download references

Acknowledgements

We thank members and staff of the Hamaguchi Laboratory for their technical assistance and helpful discussions. This work was supported by a Grant-in-Aid for Center of Excellence (COE) Research from the Ministry of Education, Science, Sports and Culture of Japan, and a grant under the Monbusho International Scientific Research Program.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michinari Hamaguchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruhul Amin, A., Machida, K., Oshima, K. et al. A role for SHPS-1/SIRPα1 in IL-1β- and TNFα-dependent signaling. Oncogene 21, 8871–8878 (2002). https://doi.org/10.1038/sj.onc.1206018

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206018

Keywords

This article is cited by

Search

Quick links